Month: February 2021

ANN ARBOR, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a  veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.Zomedica also has granted to the underwriter a 30-day option to purchase up to 13,697,368 additional common shares...

TULSA, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) reports that the Company has achieved record net revenues in January 2021 totaling approximately $11.9 million, an increase of $6.6 million, or 125% over net revenues in January 2020.  The Company’s Usborne Books & More (UBAM) division also finished January 2021 with approximately 59,100 active consultants, an increase of 85% over the number of active consultants at the end of January last year.    Per Randall White, Chief Executive Officer, “We are pleased to announce continued record monthly net revenues in our fiscal fourth quarter.  Our UBAM division generated approximately $11.1 million of net revenues in January 2021, an increase of 141%, over the prior year’s January net...

TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) — Martina Minerals Corp. (the “Corporation”) (NEX: MTN.H) is pleased to that it has negotiated various debt conversion agreements (collectively, the “Debt Agreements”) with five (5) creditors (collectively, the “Creditors”).Pursuant to the terms of the Debt Agreements, the Corporation has agreed to issue an aggregate of 4,500,000 common shares (“Debt Shares”) to the Creditors in exchange for the cancellation of $225,000 in debt owing to the parties. The Debt Shares are being issued at a deemed price of $0.05.The issuance of the Debt Shares are subject to the approval of NEX. All securities issued pursuant to the debt conversion are subject to a statutory four (4) month hold period.Corporation contact:Herbert M. BrughPresident and DirectorTel: 416.945.6628Neither TSX Venture Exchange nor its...

SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the pricing of its previously announced underwritten public offering. The Company will sell 5,410,628 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to Sientra, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $36.5 million. The offering is expected to close on or about February 11, 2021, subject to customary closing conditions. In addition, the Company has granted the underwriters a 30-day option to purchase up to 811,594 additional shares at the public offering price, less underwriting discounts and commissions.Sientra...

Glen Rock, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has been up listed from the OTC Pink Market and returns to the OTCQB Venture Market, effective with opening of the markets today, Monday, February 8, 2021.Additionally, the Company’s ticker symbol has returned to RSPI and is no longer RSPID.About RespireRx Pharmaceuticals Inc.The mission of the Company is to develop innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling. We are developing treatment options that address conditions that affect millions of people, but for which there are limited or poor treatment options, including obstructive sleep apnea (“OSA”), attention deficit hyperactivity disorder (“ADHD”), epilepsy, chronic pain, including inflammatory...

BANNOCKBURN, Ill., Feb. 08, 2021 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 15,000,000 shares of the Company’s common stock at a price to the public of $18.50 per share in an underwritten public offering. The number of shares of common stock to be sold was increased to 15,000,000 shares from the previously announced 10,000,000 shares. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 2,250,000 additional shares of common stock. The offering is expected to close on February 10, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the offering.This sale of shares represents approximately...

AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) — Ideal Power Inc. (Nasdaq: IPWR) (the “Company” or “Ideal Power”), pioneering the development and commercialization of highly efficient and broadly patented B-TRAN™ bi-directional power switches, today announced the pricing of an underwritten public offering of 1,176,500 shares of its common stock at a public offering price of $17.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $20 million. In addition, the Company has granted the underwriter a 30-day option to purchase up to an additional 176,475 shares of its common stock, less underwriting discounts and commissions. The proceeds to the Company from this offering are expected to be approximately $18.35 million after deducting underwriting discounts and commissions and other estimated...

GUANGZHOU, China, Feb. 08, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it plans to release its unaudited fourth quarter and full year 2020 financial results before the U.S. market opens on March 11, 2021. Following the release, company management will host a conference call at 8:00 a.m. ET on (9:00 p.m. Hong Kong time) the same day to discuss its financial results for the fourth quarter and full year 2020.Details of the conference call are as follows:A replay of the fourth quarter and full year 2020 financial results conference call will be available for one week (dial-in number: +61 2 8199 0299; same conference ID as shown above).Please...

SAN CLEMENTE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that noted real estate and healthcare attorney James Callister has joined the Company as General Counsel and Secretary. CareTrust also announced that Lauren Beale, CareTrust’s Controller, has been promoted to Senior Vice President and Controller.“Lauren and James have both been invaluable contributors to our success since CareTrust’s inception almost seven years ago,” said Greg Stapley, CareTrust’s Chairman and Chief Executive Officer. “In their new roles, they further strengthen an already top-performing management team and solidify CareTrust’s prospects for an ever-brighter future,“ he added.Mr. Stapley called Ms. Beale an indispensable member of the core team that has produced CareTrust’s industry-leading success since 2014....